Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 19.70
-0.11 (-0.56%)
Feb 13, 2026, 3:00 PM CST
SHA:688670 Market Cap
SHA:688670 has a market cap or net worth of 2.43 billion as of February 13, 2026. Its market cap has increased by 65.96% in one year.
Market Cap
2.43B
Enterprise Value
2.32B
Revenue
116.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.70
Market Cap Chart
Since August 2, 2021, SHA:688670's market cap has decreased from 7.30B to 2.43B, a decrease of -66.74%. That is a compound annual growth rate of -21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.43B | -2.62% |
| Dec 31, 2025 | 2.49B | 66.91% |
| Dec 31, 2024 | 1.49B | -57.41% |
| Dec 29, 2023 | 3.51B | -7.32% |
| Dec 30, 2022 | 3.78B | -43.20% |
| Dec 31, 2021 | 6.66B | -8.72% |
| Aug 2, 2021 | 7.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Universal Biotech | 2.88B |
| Landfar Bio-medicine | 2.86B |
| Shandong Sito Bio-technology | 2.82B |
| Shanghai Serum Bio-Technology | 2.82B |
| Jilin Jian Yisheng Pharmaceutical | 2.76B |
| Jiangsu CoWin Biotech | 2.73B |
| Jiangsu Sihuan Bioengineering | 2.63B |
| Hubei Goto Biopharm | 2.47B |